Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 2E1 (CYP2E1) is a member of the cytochrome P450 superfamily of enzymes involved in the metabolism of a wide range of compounds. It metabolizes small organic molecules, including ethanol, acetone, and toxic environmental chemicals. CYP2E1 plays a dual role in detoxification and bioactivation of procarcinogens. Its expression is induced by ethanol, diabetes, and starvation, leading to increased metabolic capacity and ROS production. Elevated CYP2E1 activity is implicated in liver diseases, cancer, and heart disease. There are significant inter-individual differences in hepatic CYP2E1 levels, influencing individual responses to drugs and susceptibility to toxic effects.
N/A
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 2E1 (CYP2E1).